Author

Logan Langerude

Northwestern University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Amir M. EmtiazjooiD· 2 shared Blake GilliD· 2 shared Carl AtkinsoniD· 2 shared Ashish Kumar SharmaiD· 1 shared Ashish Ranjan SharmaiD· 1 shared Christine M. LiniD· 1 shared Dianna NordiD· 1 shared Hassan Moussa· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Amir M. EmtiazjooORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exogenous BMP9 therapy ameliorates primary graft dysfunction post lung transplantation

Blake Gill, Zhenxiao Tu, Logan Langerude, Amir M. Emtiazjoo, Ashish Kumar Sharma, Carl Atkinson

This study shows that BMP9 therapy reduces primary graft dysfunction after lung transplantation by improving endothelial function and reducing inflammation.

bioRxiv · Sep 30, 2025 · PreprintImmunology

Predicting Primary Graft Dysfunction in Lung Transplantation: Machine Learning-Guided Biomarker Discovery

Dianna Nord, Jason Cory Brunson, Logan Langerude, Hassan Moussa, Blake Gill, Tiago Machuca, Mindaugas Račkauskas, Ashish Ranjan Sharma, Christine M. Lin, Amir M. Emtiazjoo, Carl Atkinson

This study uses machine learning to identify cytokines predictive of primary graft dysfunction in lung transplantation, finding BAL fluid at 2h post-transplant as the strongest predictor.

bioRxiv · May 24, 2024 · PreprintImmunology